Literature DB >> 2833104

Clonal rearrangement for immunoglobulin and T-cell receptor genes in systemic Castleman's disease. Association with Epstein-Barr virus.

C A Hanson1, G Frizzera, D F Patton, B A Peterson, K L McClain, K J Gajl-Peczalska, J H Kersey.   

Abstract

Castleman's disease is a morphologically and clinically heterogeneous lymphoproliferative disorder. Both a localized benign variant and an aggressive form with systemic manifestations have been described. To investigate the differences between these variants of Castleman's disease, the authors analyzed lymph node DNA from 4 patients with the localized type and 4 with the systemic type of Castleman's disease for immunoglobulin and T-cell receptor gene rearrangements. The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) was also studied by viral genomic DNA probes. They detected clonal rearrangements in 3 of the 4 patients with the systemic variant of Castleman's; no patients with localized disease had rearrangements. Copies of EBV genome were also detected in 2 of the 3 patients with clonal rearrangements. These results suggest that systemic Castleman's disease is a disorder distinct from the classical localized variant in that it may evolve into a clonal lymphoproliferation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833104      PMCID: PMC1880570     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

Review 1.  Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

Authors:  D W Hanto; G Frizzera; K J Gajl-Peczalska; R L Simmons
Journal:  Transplantation       Date:  1985-05       Impact factor: 4.939

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Castleman's lymphoadenopathy: twenty years of observation. II. Generalized form.

Authors:  T Artusi; G Bonacorsi; A Saragoni; M Spedicato; G Rinaldi; M Federico; V Silingardi
Journal:  Haematologica       Date:  1982-02       Impact factor: 9.941

4.  A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients.

Authors:  G Frizzera; B A Peterson; E D Bayrd; A Goldman
Journal:  J Clin Oncol       Date:  1985-09       Impact factor: 44.544

5.  Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.

Authors:  D L Birx; R R Redfield; G Tosato
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

6.  Giant lymph node hyperplasia associated with thrombotic thrombocytopenic purpura.

Authors:  W D Couch
Journal:  Am J Clin Pathol       Date:  1980-09       Impact factor: 2.493

7.  Multicentric giant lymph node hyperplasia clinically simulating angioimmunoblastic lymphadenopathy. Associated Kaposi's sarcoma in two of three cases.

Authors:  E Kessler; R Beer
Journal:  Isr J Med Sci       Date:  1983-03

8.  Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms.

Authors:  A Arnold; J Cossman; A Bakhshi; E S Jaffe; T A Waldmann; S J Korsmeyer
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

9.  Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease.

Authors:  L M Weiss; G S Wood; M Trela; R A Warnke; J Sklar
Journal:  N Engl J Med       Date:  1986-08-21       Impact factor: 91.245

10.  Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.

Authors:  M Ho; G Miller; R W Atchison; M K Breinig; J S Dummer; W Andiman; T E Starzl; R Eastman; B P Griffith; R L Hardesty
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

View more
  7 in total

1.  Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.

Authors:  S J Brandt; D M Bodine; C E Dunbar; A W Nienhuis
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

2.  Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman's disease.

Authors:  P Barozzi; M Luppi; L Masini; R Marasca; M Savarino; M Morselli; M G Ferrari; M Bevini; G Bonacorsi; G Torelli
Journal:  Clin Mol Pathol       Date:  1996-08

3.  Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity?

Authors:  J O'Leary; M Kennedy; D Howells; I Silva; V Uhlmann; K Luttich; S Biddolph; S Lucas; J Russell; N Bermingham; M O'Donovan; M Ring; C Kenny; M Sweeney; O Sheils; C Martin; S Picton; K Gatter
Journal:  Mol Pathol       Date:  2000-04

4.  Genetic changes in atypical hyperplasia and lymphoma with angioimmunoblastic lymphadenopathy and dysproteinaemia in the same patients.

Authors:  K Ohshima; M Kikuchi; M Hashimoto; M Kozuru; N Uike; S Kobari; Y Masuda; Y Sumiyoshi; S Yoneda; M Takeshita
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Intestinal lymphangiectasia associated with angiofollicular lymph node hyperplasia (Castleman's disease).

Authors:  S F Moss; D M Thomas; C Mulnier; I G McGill; H J Hodgson
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

6.  Clinical Analysis of Castleman's Disease of the Lacrimal Gland.

Authors:  Dongping Li; Dongrun Tang; Fengyuan Sun
Journal:  J Ophthalmol       Date:  2020-11-23       Impact factor: 1.909

Review 7.  A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease.

Authors:  Alexandra Butzmann; Jyoti Kumar; Kaushik Sridhar; Sumanth Gollapudi; Robert S Ohgami
Journal:  Biology (Basel)       Date:  2021-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.